Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Gabriella Jensen"'
Autor:
Rachele Rossi, Camilla Johansson, Wendy Heywood, Heloise Vinette, Gabriella Jensen, Hanna Tegel, Albert Jiménez-Requena, Silvia Torelli, Cristina Al-Khalili Szigyarto, Alessandra Ferlini
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 6, p 5215 (2023)
Duchenne muscular dystrophy (DMD) is a rare neuromuscular disease caused by pathogenic variations in the DMD gene. There is a need for robust DMD biomarkers for diagnostic screening and to aid therapy monitoring. Creatine kinase, to date, is the only
Externí odkaz:
https://doaj.org/article/c5c5b02a800d410386154a75561e5c74
Autor:
Sophia Hober, Cecilia Hellström, Jennie Olofsson, Eni Andersson, Sofia Bergström, August Jernbom Falk, Shaghayegh Bayati, Sara Mravinacova, Ronald Sjöberg, Jamil Yousef, Lovisa Skoglund, Sara Kanje, Anna Berling, Anne‐Sophie Svensson, Gabriella Jensen, Henric Enstedt, Delaram Afshari, Lan Lan Xu, Martin Zwahlen, Kalle vonFeilitzen, Leo Hanke, Ben Murrell, Gerald McInerney, Gunilla B Karlsson Hedestam, Christofer Lendel, Robert G Roth, Ingmar Skoog, Elisabet Svenungsson, Tomas Olsson, Anna Fogdell‐Hahn, Ylva Lindroth, Maria Lundgren, Kimia T Maleki, Nina Lagerqvist, Jonas Klingström, Rui Da Silva Rodrigues, Sandra Muschiol, Gordana Bogdanovic, Laila Sara Arroyo Mühr, Carina Eklund, Camilla Lagheden, Joakim Dillner, Åsa Sivertsson, Sebastian Havervall, Charlotte Thålin, Hanna Tegel, Elisa Pin, Anna Månberg, My Hedhammar, Peter Nilsson
Publikováno v:
Clinical & Translational Immunology, Vol 10, Iss 7, Pp n/a-n/a (2021)
Abstract Objective The COVID‐19 pandemic poses an immense need for accurate, sensitive and high‐throughput clinical tests, and serological assays are needed for both overarching epidemiological studies and evaluating vaccines. Here, we present th
Externí odkaz:
https://doaj.org/article/8b5b60f5e8974c2ab35d2703899e52f2